profit from every $100 of sales.
$0$100
Microbot Medical
$1.11+5.71% today
-46.9% in 1 year
1-year low $0.941-year high $2.85
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Microbot Medical sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with -$13.1 million of profit last year.
SalesProfit
Microbot Medical vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Microbot Medical | No profit yet | ||
 ResMed | 22.0× · Fair price | ||
 West Pharmaceutical Services | 58.3× · Expensive | ||
 Hologic | 30.0× · Fair price | ||
 Baxter International | No profit yet |
AI analysis
An AI analyst reads Microbot Medical's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -13 | -10 | -12 | -15 | |
| -13 | -10 | -12 | -15 | |
| -13 | -11 | -11 | -13 | |
| -1.81 | -1.05 | -0.73 | -0.29 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 10 | 8 | 6 | 82 |
| Cash | 2 | 2 | 3 | 4 |
| Total debt | 0 | 0 | 0 | 1 |
| Total liabilities | 2 | 4 | 3 | 4 |
| 7 | 5 | 4 | 78 | |
| 7 | 10 | 16 | 46 | |
| -137.0% | -169.2% | -252.2% | -14.9% | |
| -180.7% | -238.6% | -324.2% | -16.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -12 | -9 | -9 | -13 | |
| 0 | 0 | 0 | 0 | |
| -12 | -9 | -9 | -13 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 2 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 1.8×
- –
- –
- –
- -17.6%
- -17.6%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -18.8%
- -160.6%
- -24.4%
- -16.1%
- -18.9%
- –
Growth
- –
- –
- −48.1%
- –
- +59.3%
Financial health
- 0.2×
- 0.01
- 1.1%
- –
- 23.33
- 23.16
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 20%of 958
Bottom 21%of 888
Bottom 5%of 987
What analysts expect
- Average price target
- $5.50
- Range
- $5.50 – $5.50
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.05 | -0.08 | +37.5% |
| Mar 26, 2026 | -0.04 | -0.06 | +33.3% |
| Nov 12, 2025 | -0.07 | -0.06 | −16.7% |
| Aug 12, 2025 | -0.10 | -0.08 | −25.0% |
| May 14, 2025 | -0.08 | -0.13 | +38.5% |
| Mar 25, 2025 | -0.20 | -0.18 | −11.1% |
| Nov 13, 2024 | -0.20 | -0.17 | −17.6% |
| Aug 14, 2024 | -0.17 | -0.17 | +0.0% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
28No pass
Benjamin Graham
55No pass
Philip Fisher
34No pass
Peter Lynch
60Pass
Joel Greenblatt
0No pass
Charlie Munger
30No pass
Terry Smith
30No pass
Questions about Microbot Medical
Is Microbot Medical a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Microbot Medical AI analysis
What does Microbot Medical do?
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is in Medical - Instruments & Supplies.
Does Microbot Medical pay a dividend?
No. Microbot Medical does not pay a dividend at the moment.
Is Microbot Medical stock halal?
Questionable. Microbot Medical sits in a grey zone: short-term investments may earn interest; type not reported. How we check
How has Microbot Medical stock done over the past year?
Down 46.9% over the past twelve months, to $1.11. It traded between $0.94 and $2.85 and is 61.1% below its high.
Who are Microbot Medical's competitors?
The largest listed companies in the same industry are ResMed, West Pharmaceutical Services, Hologic and Baxter International. The peers table on this page compares their profit, growth and price with Microbot Medical's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.